Persistent Asthma Clinical Trial
— ACT MeOfficial title:
Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care.
A randomized controlled trial of a texting intervention to increase adherence to preventative asthma medication in four Cincinnati Children's Hospital Medical Center primary care clinics.
Status | Completed |
Enrollment | 29 |
Est. completion date | December 2015 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 12 Years to 21 Years |
Eligibility |
Inclusion Criteria: - provider-diagnosed persistent asthma - prescription of an ICS in accordance in NHLBI Expert Panel Report 3 guidelines for at least 30 days prior to enrollment - Asthma Control Test (ACT) score less than 20 (indicating lack of current control) - no provider-diagnosed exacerbation in the 30 days prior to enrollment - possession of a text-enabled cell phone and a plan to keep it throughout the study period - agreement by parents (or participants over 18 years old) to any charges levied by their cell phone carrier for text messages associated with the study if they do not have an unlimited texting plan - speak and read English Exclusion Criteria: - another chronic lung disease (which would complicate measurement of asthma control) - cognitive or psychiatric disorder that the treating clinician judges would impair study participation - use of Advair diskus for their ICS (for which no reliable electronic monitor exists) - current enrollment in another asthma intervention study |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio |
Lead Sponsor | Collaborator |
---|---|
Children's Hospital Medical Center, Cincinnati | National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Objective Adherence to ICS | Electronic monitor logs | Baseline | No |
Primary | Change in objective adherence to ICS | Electronic Monitor Logs | Change from baseline in objective adherence to ICS at 1 month | No |
Primary | Change in objective adherence to ICS | Electronic Monitor Logs | Continuous change over time from baseline in objective adherence to ICS at 2 months in intervention compared to control | No |
Primary | Change in objective adherence to ICS | Electronic Monitor Logs | Continuous change over time from baseline in objective adherence to ICS at 3 months in intervention compared to control | No |
Primary | Change in objective adherence to ICS | Electronic Monitor Logs | Continuous change over time from baseline in objective adherence to ICS at 4 months in intervention compared to control | No |
Primary | Change in objective adherence to ICS | Electronic Monitor Logs | Continuous change over time from baseline in objective adherence to ICS at 5 months in intervention compared to control | No |
Primary | Feasibility, Acceptability and Usability of the Text Messaging Website | The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs. | At time of text messaging intervention | No |
Primary | Feasibility, Acceptability and Usability of the Text Messaging Website | The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs. | up to 1 month after receiving text messages | No |
Primary | Feasibility, Acceptability and Usability of the Text Messaging Website | The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs. | up to 2 months after receiving text messages | No |
Primary | Feasibility, Acceptability and Usability of the Text Messaging Website | The Computer System Usability Questionnaire is a self-reported measure that captures quantitative data about the usability of the computer system. The Cincinnati Bell Usability questionnaire is a self-reported measure that captures quantitative and qualitative data about how easy the system is to use, whether they like using it, as well as likes and dislikes. Use of the computer system is determined through CMSText website login and message logs. | up to 3 months after receiving text messages | No |
Secondary | Asthma Control | The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. | Baseline | No |
Secondary | Change in Asthma Control | The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. | Change from Baseline at 1 month | No |
Secondary | Change in Asthma Control | The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. | Continuous change over time from baseline at 2 months in intervention compared to control | No |
Secondary | Change in Asthma Control | The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. | Continuous change over time from baseline at 3 months in intervention compared to control | No |
Secondary | Change in Asthma Control | The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. | Continuous change over time from baseline at 4 months in intervention compared to control | No |
Secondary | Change in Asthma Control | The Asthma Control Test (ACT) are questions that ask about frequency of day and night symptoms, frequency of fast acting inhaler use, environmental triggers, limitations of activities, perception of asthma control, and confidence in ability to manage asthma. | Continuous change over time from baseline at 5 months in intervention compared to control | No |
Secondary | Asthma Symptoms, Quality of Life, Treatment Barriers | The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. | Baseline | No |
Secondary | Change in Asthma Symptoms, Quality of Life, Treatment Barriers | The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. | Change from Baseline at month 1 | No |
Secondary | Change in Asthma Symptoms, Quality of Life, Treatment Barriers | The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. | Continuous change over time from baseline at 2 months in intervention compared to control | No |
Secondary | Change in Asthma Symptoms, Quality of Life, Treatment Barriers | The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. | Continuous change over time from baseline at 3 months in intervention compared to control | No |
Secondary | Change in Asthma Symptoms, Quality of Life, Treatment Barriers | The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. | Continuous change over time from baseline at 4 months in intervention compared to control | No |
Secondary | Change in Asthma Symptoms, Quality of Life, Treatment Barriers | The Pediatric Quality of Life (PEDSQL) Asthma Symptom Scale, the generic core scale and the treatment barriers scale are questions that assess how much asthma has been a problem for them in the last month. | Continuous change over time from baseline at 5 months in intervention compared to control | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02513160 -
Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
|
Phase 3 | |
Active, not recruiting |
NCT02883530 -
Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study
|
||
Completed |
NCT02003521 -
Impact of Lung Flute Therapy on Asthma
|
N/A | |
Completed |
NCT01253603 -
Efficacy, Safety, and Pharmacokinetics of QAW039
|
Phase 2 | |
Completed |
NCT01845025 -
Study of Safety of Foradil in Patients With Persistent Asthma
|
Phase 4 | |
Not yet recruiting |
NCT02053402 -
Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital
|
Phase 4 | |
Completed |
NCT01156844 -
Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol
|
Phase 2 | |
Completed |
NCT01078688 -
Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma
|
N/A | |
Completed |
NCT02026336 -
E-nose and Inflammatory Asthma Phenotypes
|
N/A | |
Withdrawn |
NCT04271839 -
Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients
|
Phase 4 | |
Active, not recruiting |
NCT04480242 -
Asthma Research in Children and Adolescents
|
||
Completed |
NCT02175771 -
Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
|
Phase 3 | |
Completed |
NCT01147510 -
Asthma Control in Elderly Patients With Montelukast
|
Phase 4 | |
Completed |
NCT03541187 -
Cockroach Immunotherapy in Children and Adolescents
|
Phase 2 | |
Completed |
NCT02040779 -
A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
|
Phase 3 | |
Active, not recruiting |
NCT05843045 -
Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma
|
N/A |